A61P 1 - Drugs for disorders of the alimentary tract or the digestive system

Patents for A61P 1 - Drugs for disorders of the alimentary tract or the digestive system (125,798)
12/2004
12/08/2004	EP1484333A1 New aminopropylphosphonous acids
12/08/2004	EP1484332A2 Lipid-based drug delivery system for administration of a drug substance
12/08/2004	EP1484320A1 Jnk inhibitor
12/08/2004	EP1484065A1 Chinese preparation for treating enteritis ulcer colitis and preparation method thereof
12/08/2004	EP1484061A1 Drugs containing riboflavin-type compounds
12/08/2004	EP1483396A2 Wit 3.0, novel gene to control soft tissue wound healing
12/08/2004	EP1483384A2 Method for overexpression of zwitterionic polysaccharides
12/08/2004	EP1483370A2 Hepatocyte precursor cell lines
12/08/2004	EP1483366A1 Antimicrobial composition
12/08/2004	EP1483289A2 Angiogenesis regulator genes, pharmaceutical preparations containing same and uses thereof
12/08/2004	EP1483284A2 Selective dipeptide inhibitors of kallikrein
12/08/2004	EP1483266A1 Spiro compounds with npy antagonistic activity
12/08/2004	EP1483263A1 Thiazolyl urea compounds for the treatment of cancer
12/08/2004	EP1483244A1 Cyclic n-substituted alpha iminocarboxylic acids for selectively inhibiting collagenase
12/08/2004	EP1483242A1 Nitrosodiphenylamine derivatives and their pharmaceutical use against oxidative stress pathologies
12/08/2004	EP1483236A1 Aminoalcohol derivatives as beta-3 adrenergic receptor agonists
12/08/2004	EP1483232A1 Salts of nateglinide
12/08/2004	EP1483228A1 Nk1 antagonists
12/08/2004	EP1482984A2 Surrogate antibodies and methods of preparation and use thereof
12/08/2004	EP1482973A1 Methods of modulating cd200 receptors
12/08/2004	EP1482972A2 Treatment of immunological disorders using anti-cd30 antibodies
12/08/2004	EP1482962A2 Method of treating trx mediated diseases
12/08/2004	EP1482960A2 Methods and products for oral care
12/08/2004	EP1482955A1 Prophylactic and therapeutic treatment of infectious and other diseases with immunoeffector compounds
12/08/2004	EP1482951A1 Alpha-hydroxy-2-methylene-10-nor-pregnacalciferol and its uses
12/08/2004	EP1482942A2 Stabilized pharmaceutical compositions of halofuginone and other quinazolinone derivatives
12/08/2004	EP1482941A1 Beta-sheet mimetics and composition and methods relating thereto
12/08/2004	EP1482937A2 Novel tyloindicines and related processes, pharmaceutical compositions and methods
12/08/2004	EP1482932A1 N3 alkylated benzimidazole derivatives as mek inhibitors
12/08/2004	EP1482928A2 Mediators of hedgehog signaling pathways,compositions and uses related thereto
12/08/2004	EP1482926A2 Amino-methyl substituted tetracycline compounds
12/08/2004	EP1482924A2 Cathepsin cysteine protease inhibitors
12/08/2004	EP1482918A2 Utilization of ubiquinones for influencing the effect of histamine
12/08/2004	EP1482917A1 Compositions comprising cannabinoids for treatment of nausea, vomiting, emesis, motion sickness or like conditions
12/08/2004	EP1482911A1 Dispersed solid-containing complex carbohydrate
12/08/2004	EP1482896A2 Aminoalkylphosphonates and related compounds as edg receptor agonists
12/08/2004	EP1482895A2 Aminoalkylphosphonates and related compounds as edg receptor agonists
12/08/2004	EP1482811A1 Probiotic delivery system
12/08/2004	EP1434886A4 Mid 241 receptor, a novel g-protein coupled receptor
12/08/2004	EP1363898A4 Compounds useful as modulators of melanocortin receptors and pharmaceutical compositions comprising same
12/08/2004	EP1341754B1 Substituted anthranilic acids
12/08/2004	EP1240152B1 Ox(adi)azolyl-hydroxamic acids useful as procollagen c-proteinase inhibitors
12/08/2004	EP1221947B1 Soft gel capsule resistant to gastric juices
12/08/2004	EP1220856B1 Pyrazolo[4,3-d]pyrimidine derivatives
12/08/2004	EP1141014B1 Insulin-like growth factor (igf) i mutant variant
12/08/2004	EP0801570B1 Formulations and methods for reducing skin irritation
12/08/2004	CN1553910A Heterocyclylindazole and -azaindazole compounds as 5-hydroxytryptamine-6 ligands
12/08/2004	CN1553901A New pyrimidine-2,4,6-trione derivatives, processes for their production and pharmaceutical agents containing these compounds
12/08/2004	CN1553892A Novel compounds and compositions as cathepsin inhibitors
12/08/2004	CN1553806A Use of SAPR-1 for the treatment and/or prevention of scleroderma
12/08/2004	CN1553804A Combinations for the treatment of inflammatory disorders
12/08/2004	CN1553800A Napthoquinone derivatives as inhibitors of tau aggregation for the treatment of alzheimer's and related neurodegenerative disorders
12/08/2004	CN1553799A Dosage forms having prolonged active ingredient release
12/08/2004	CN1553784A Magnetic resonance imaging method and device and RF receiving coil therefor
12/08/2004	CN1552894A Corn peptide and its preparation and use
12/08/2004	CN1552727A Targetted polypeptide for specificity of liver cancer blood vessel
12/08/2004	CN1552710A Use of aspergillus fumigatus in antiflammation immunosuppressant
12/08/2004	CN1552708A Three compounds from traditional Chinese medicine
12/08/2004	CN1552707A 4-aryl group-5H-thoifuran-2-ketone derivative, producing method and use thereof
12/08/2004	CN1552447A Adjuvant for improving hepatitis B vaccine immune effect and preparing method thereof
12/08/2004	CN1552446A Nucleic acid vaccin for preventing and treating hepatitis B virus inflammation and its preparation
12/08/2004	CN1552445A Medicinal preparation for preventing from pyloric helicobacterium inflammation
12/08/2004	CN1552443A Lysozyme injection preparation
12/08/2004	CN1552426A Chinese patent drug for treatnig liver fibration and cirrhosis, preparing method for its preparation
12/08/2004	CN1552421A Medicine for treating stomach trouble and duodenal ulcer
12/08/2004	CN1552413A Internal medicine for treating SARS, AIDS virus, preparing method and use thereof
12/08/2004	CN1552410A Preparation of capsules of Dangfeiliganning
12/08/2004	CN1552409A Medicine composition for preparing canker and preparing method thereof
12/08/2004	CN1552408A Preparnig method for xiao Chaihu effervescent preparation and quality controlling method thereof
12/08/2004	CN1552405A Clearing heat and detoxicating medicine
12/08/2004	CN1552386A Medicine for treating human lithic disease
12/08/2004	CN1552384A Yilingjing pills and their preparation
12/08/2004	CN1552382A Snow mountain stomach nourishing micro-pills and their preparation
12/08/2004	CN1552381A Antiphlogistic cholagogic pill and preparing method thereof
12/08/2004	CN1552380A Four season three-yellow micro-pills and their preparation
12/08/2004	CN1552378A Blood regenerating pills and their preparation
12/08/2004	CN1552377A Kidney and liver relieving pills and their preparation
12/08/2004	CN1552376A Light relaxing pills and their preparation
12/08/2004	CN1552375A Chronic hepatitis yin nourishing pills and their preparation
12/08/2004	CN1552374A Maren bowel nourishing micro-pills and their preparation
12/08/2004	CN1552370A Compound fresh herba dendrobill pills and their preparation
12/08/2004	CN1552369A Compound tangerine peel and nutgrass flatsedge rhizome pills for stomach and their preparation
12/08/2004	CN1552366A Donkey hide gelatin and Chinese angelica nourishing blood pills and their preparation
12/08/2004	CN1552361A Kidney pills and their preparation
12/08/2004	CN1552354A Sour and hot tablets for appetising and loosing bowel
12/08/2004	CN1552351A Pure Chinese medicine preparation for treatinog peptic ulcer and preparing method thereof
12/08/2004	CN1552344A Alinate/alginic acid composition
12/08/2004	CN1552326A Method for stabilizing intravenous injection of azasejoin
12/08/2004	CN1178955C Modified TNF alpha molecules and DNA encoding such modified TNF alpha molecules and vaccines comprising such modified TNF alpha molecules and DNA
12/08/2004	CN1178941C CRF receptor antagonists and method relating thereof
12/08/2004	CN1178940C Selective antagonists of A28 adenosine receptors
12/08/2004	CN1178936C Sulfonyl-pyrrolidine derivatives
12/08/2004	CN1178932C Amide derivatives
12/08/2004	CN1178927C Histamine H3 receptor ligands
12/08/2004	CN1178923C 1,4-diazepan-2,5-dione derivatives and their use as NK-1 receptor antagonists
12/08/2004	CN1178922C Substituted 1-aminoalkyl-lactams compound and their use as muscarinic receptor antagonists
12/08/2004	CN1178917C N-oxides as NK1 receptor antagonist prodrugs of 4-phenyl-pyridine derivatives
12/08/2004	CN1178906C N-hydroxyformamide derivatives as inhibitors of matrix metalloproteinases
12/08/2004	CN1178905C Novel peptide derivative
12/08/2004	CN1178692C Production process of healthy soybean oral liquid

1 ... 744 745 746 747 748 749 750 751 752 753 754 755 756 757 758 759 760 761 762 763 764 ... 1258